Lin Elizabeth Yeu: insider trades.
Lin Elizabeth Yeu reported 7 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 7 sales ($2.1M), across 1 company.
- Transactions
- 7
- Purchases (P)
- 0
- Sales (S)
- 7
- Companies
- 1
- Name as filed
- Lin Elizabeth Yeu
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | Officer · Chief Medical Officer | 7 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-04 | Tarsus Pharmaceuticals, Inc. | S | 1,590 | $85 | 3,180 | Form 4 |
| 2026-09-04 | Tarsus Pharmaceuticals, Inc. | S | 1,590 | $90 | 1,590 | Form 4 |
| 2026-09-04 | Tarsus Pharmaceuticals, Inc. | S | 5,387 | $85 | 7,933 | Form 4 |
| 2026-09-04 | Tarsus Pharmaceuticals, Inc. | S | 5,386 | $90 | 2,547 | Form 4 |
| 2026-09-02 | Tarsus Pharmaceuticals, Inc. | S | 1,590 | $80 | 4,770 | Form 4 |
| 2026-09-02 | Tarsus Pharmaceuticals, Inc. | S | 5,387 | $80 | 13,320 | Form 4 |
| 2026-09-01 | Tarsus Pharmaceuticals, Inc. | S | 4,601 | $73.86 | 18,707 | Form 4 |
Questions
What stock did Lin Elizabeth Yeu buy or sell?
Lin Elizabeth Yeu reported 7 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 7 sales ($2.1M), across 1 company.
Is Lin Elizabeth Yeu the same person as other filers with this name?
This page covers SEC CIK 1842190 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/lin-elizabeth-yeu-1842190.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.